Anixa Biosciences, Inc. earnings per share and revenue
On 08 de jan. de 2026, ANIX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.08 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.17% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analistas forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Anixa Biosciences, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Anixa Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Anixa Biosciences, Inc.'s Q4 2025 earnings?
The stock price moved down -1.17%, changed from $3.42 before the earnings release to $3.38 the day after.
When is Anixa Biosciences, Inc. expected to report next?
The next earning report is scheduled for 09 de mar. de 2026.
What are the forecasts for Anixa Biosciences, Inc.'s next earnings report?
Based on 5
analistas, Anixa Biosciences, Inc. is expected to report EPS of -$0.10 and revenue of -- for Q1 2026.